Noubar Afeyan

Noubar Afeyan is a Massachusetts-based healthcare figure born in 1962, with an estimated net worth of ~$1.9 billion. SEC records connect him with biotechnology and healthcare companies including Moderna, Seres Therapeutics, Editas Medicine, Denali Therapeutics, and Syros Pharmaceuticals. He has also signed the Giving Pledge. RTB SEC EDGAR The Giving Pledge

Business & SEC Activity

SEC records list 321 filings for Afeyan, including 293 insider filings. Forms 3 generally report an insider's initial ownership, while Forms 4 report later changes in ownership; the available record includes both types, with recent Form 4 filings in 2026. SEC EDGAR

Philanthropy

Two foundations associated with Afeyan reported $5.92 million in grants paid for tax year 2023. The Afeyan Family Foundation reported $2.26 million in grants, while the Afeyan Foundation for Armenia reported $3.66 million; together, the foundations reported $18.04 million in assets. ProPublica 990

Political Activity

Federal Election Commission records show 37 contributions totaling $76,320 from June 1995 through September 2025. Contributions totaled $39,650 to Democratic recipients, $7,800 to Republican recipients, and $28,870 to recipients whose party was not identified in the data; the largest recipient was the Armenian American PAC, with $15,000. FEC

In the News

Recent headlines associate Afeyan with biotech companies and Moderna. Coverage reported that Alltrna, a company linked to his healthcare investment network, cut 35% of its jobs before entering clinical trials, while Generate Biomedicines raised $400 million in an initial public offering and its shares fell 6% in a weak Nasdaq debut. NewsAPI